Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients
Justin de Brabander*, Erik Duijvelaar, the CounterCOVID Study Group, Job R. Schippers, Patrick J. Smeele, Hessel Peters-Sengers, Jan Willem Duitman, Jurjan Aman, Harm J. Bogaard, Tom van der Poll, Lieuwe D.J. Bos
Research output: Contribution to journal › Article › Academic › peer-review
12Citations
(Scopus)
6Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients'. Together they form a unique fingerprint.